FRIDAY, Feb. 3 (HealthDay News) -- While a clot-busting medication can often help stop a stroke in its tracks if it's given promptly, a new study finds that a high number of stroke victims continue to fail to get to the emergency room quickly enough to get the drug. An analysis of about 115,000 patients who had strokes between 2005 and 2010 found that almost 44 percent didn't get to the hospital until more than 4.5 hours after the time they were known to first show symptoms. That's a sign of trouble: it's actually up from 39 percent in 2005. Meanwhile, the percentage who got to the hospital within two hours fell from 40 percent in 2005 to 35 percent in 2010, another sign that more patients may be in danger from not getting prompt care. Also, many patients chose to get themselves to the hospital instead of calling an ambulance, "boosting the risk that they won't get there in time to be able to take a clot-busting drug," said study co-author Dr. Mary George, a medical officer with the division for heart disease and stroke prevention at the U.S. Centers for Disease Control and Prevention. The main message of … Continue reading →

17-10-2011 14:15 This video, is a testimonial of a patient from Colorado, USA that went to Progencell, for a Stem cell treatment for her neurologic problem affecting her eyesight and hearing loss. Talks about her experience, her trip, the procedure, the outcome and some suggestions. Language english with Spanish subtitles, 2:34 min duration Read the original: Eyesight and Hearing loss - Stem Cell therapy (English) - Video … Continue reading →

(SACRAMENTO, Calif.) - Experts from UC Davis Health System will share the latest research about regenerative medicine, with a focus on chronic pain and the promise of stem cell therapies, during a community forum on the university's Sacramento campus. The discussion takes place on Tuesday, Feb. 7, from 6- 7:30 p.m. at the UC Davis Education Building, 4610 X Street, in Sacramento. The event features Jan Nolta, director of the UC Davis Institute for Regenerative Cures; Scott Fishman, chief of the UC Davis Division of Pain Medicine; and Kee Kim, chief of spinal neurosurgery at UC Davis Medical Center. The three specialists will discuss the challenges of treating chronic pain, especially back and neck pain, and the clinical research now under way to use stem cell therapies to overcome it. The forum is free and open to the public. It is part of "Stem Cell Dialogues," UC Davis Health System's discussion series about regenerative medicine and the goal of turning stem cells into cures. Each speaker will provide a short presentation followed by a panel discussion and question and answer period. The event will be moderated by Fred Meyers, professor of medicine and pathology, and executive associate dean of UC … Continue reading →

05-09-2011 07:29 They are among the best in their scientific fields. With the series "Brilliant Minds," DW-tv introduces top-notch young researchers from all over the world who live and work in Germany.Rajkumar Thummer does his research at the Life and Brain Center at the University of Bonn, one of the Germany's leading institutes for stem cell research. The 30-year-old Indian is working on ways to transform human cells back into stem cells. By using stem cells, doctors are hoping they can treat conditions like Alzheimer's disease in future. If this could be done by using stem cells from the body, problems such as patient rejection of transplanted tissue or organs could become a thing of the past. See the rest here: Brilliant Minds - Stem Cell Research | Tomorrow Today - Video … Continue reading →

02-02-2012 21:05 Stroke Treatment in Bangalore, Paralysis Treatment in Bangalore, Paralysis Treatment in Bangalore in Karnataka , Paralysis Treatment in Bangalore in Karnataka India , Paralysis Treatment , Stroke Treatment in Bangalore, Stroke Treatment Bangalore in Karnataka , Stroke Treatment in Bangalore Karnataka India , Stroke Treatment , home for aged in bangalore , old age homes, ,vrudhashram in bangalore ,old age homes in bangalore , bangalore old age home , Home For The Aged , home for mentally retarded in bangalore , home for disabled in bangalore ,home for handicapped people in bangalore ,home for mentally challenged in bangalore , home nursing services bangalore , home nurses in bangalore , home nursing , bangalore home nurse , We Provide Good Facility with Food Accommodation 24/7 Nursing care, medical, doctor,hygienic,Good Air , Garden ,Neat and Clean, old age home for movable person and bedridden,disabled people too , http://www.navachaithanya.com , Email ID : kncashramas@gmail.com , Call : Mobile 9448244695 / 9242429994 , Land 080-65655555 ( Please Save and Pass this numbers to All. It may help some one ) Regardsgs Navachaithanya , http://www.navachaithanya.com , http://www.karunaamrutha.com , http://www.dialjusts.com , http://www.karunamrutha.com , http://www.navachaithanyahomenursing.com , http://www.navachaithanyaoldagehome.com , http://www.dialjust.com , http://www.navachatanya.com , http://www.navachaitanya.com , http://www.kncarogyadhama.com … Continue reading →

(RTTNews.com) - Acorda Therapeutics, Inc. (ACOR) presented data showing that treatment with dalfampridine improved motor function in a preclinical model of stroke, with treatment initiated at least four weeks following the ischemic event. "These are the first preclinical data to show an oral pharmacologic treatment can improve function in chronic, or long term, stroke. We are excited by these results and plan to begin proof-of-concept human clinical trials of AMPYRA in people with chronic stroke later this year," said Andrew Blight, Acorda Therapeutics' Chief Scientific Officer. The company said that the presentation reviewed data from three study groups that received treatment beginning four weeks after a permanent middle cerebral artery occlusion. The neurological impairments that result are expected to be permanent by four weeks, which represents the chronic stage of stroke. Researchers assessed functional improvement using a battery of standard motor function tests in both the forelimbs and hind limbs. According to the company, in each of the three study groups, treatment with dalfampridine resulted in significant improvement in function compared to placebo across all measures during the respective treatment periods. Improvements in the high dose phase were consistently better than those seen in the low dose phase. Further, Acorda … Continue reading →

Led by Louisiana State University neurologist Dr. Nicolas Bazan, a team of researchers from several institutions has claimed a potential breakthrough in drug treatment to prevent long-term brain damage in those who suffer certain strokes. Bazan directed a study that, using laboratory rats, administered aspirin and an omega-3 essential fatty acid to yield a new protective molecule that can mitigate damage to cells around the area of an ischemic stroke. Ischemic stroke occurs when an arterial blockage denies oxygenated blood to parts of the brain, as opposed to hemorrhagic stroke, which occurs when a vessel bursts inside the brain. The results, Bazan said, portend a “novel approach for pharmaceutical intervention.” Stroke is the fourth-leading cause of death in the United States and the leading cause of newly acquired disability in adulthood. Bazan presented his findings Thursday at the International Stroke Conference, which concludes Friday at the Ernest N. Morial Convention Center in New Orleans. The study, which was financed by a National Institutes of Health grant, was designed to analyze benefits of neuroprotective agents — long a focus of Bazan’s career — that can help prevent irreversible damage in the stroke-affected area. There is considerable research interest internationally in neuroprotectors … Continue reading →